The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers.EBI
Dongguk University-Seoul
Bioactive benzofuran derivatives: moracins A-Z in medicinal chemistry.EBI
Dongguk University-Seoul
Synthesis and structure-activity relationship study of chemical probes as hypoxia induced factor-1a/malate dehydrogenase 2 inhibitors.EBI
Dongguk University-Seoul
Synthesis of a novel series of 2-alkylthio substituted naphthoquinones as potent acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors.EBI
Dongguk University-Seoul
Flavonoids as receptor tyrosine kinase FLT3 inhibitors.EBI
Dongguk University-Seoul
Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.EBI
Dongguk University-Seoul
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.EBI
Dongguk University-Seoul
Synthesis and structure-activity relationship of (E)-phenoxyacrylic amide derivatives as hypoxia-inducible factor (HIF) 1a inhibitors.EBI
Dongguk University-Seoul
HIF-1a inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.EBI
Dongguk University-Seoul
Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/HO-1 signaling.EBI
Dongguk University-Seoul
Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy.EBI
Dongguk University-Seoul